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Abstract: Background: Pelvic floor dysfunctions affect a third of the adult female population, includ-
ing a large number of clinical conditions, which can be evaluated through validated questionnaires
that inform us of the status and perception of women both objectively and subjectively. The main
objective of this study was to review and explain the topics of the validated questionnaires in Spanish
on pelvic floor dysfunctions and to review their psychometric properties. Methods: A systematic
review was carried out in the PUBMED and WOS databases. The keywords used were in PUBMED:
((((((((“Fecal Incontinence” [Mesh]) OR “Urinary Incontinence” [Mesh]) OR “Pelvic Organ Prolapse”
[Mesh]) OR “Pelvic Floor Disorders” [Mesh]) OR “Sexual Dysfunction, Physiological” [Mesh]) OR
“Pelvic Girdle Pain” [Mesh]) OR “sexual function” [Title/Abstract]) OR “Prolapse” [Title/Abstract])
AND “Surveys and Questionnaires” [Mesh] AND “Validation” [Title/Abstract] combined with the
Boolean operators “AND”/“OR”. In contrast, in WOS, a segregated search was carried out with
each of the terms of pelvic floor dysfunction together with “Validation” and “Surveys and Question-
naires”. All articles published up to 19 November 2021 were considered. Methodological quality
was assessed with the COSMIN scale. Results: A total of 687 articles were identified, of which 13
were included. The evaluated questionnaires and the structural characteristics and psychometric
properties of each of them were collected. Conclusion: The Spanish versions of the questionnaires
show good basic structural and psychometric characteristics for the evaluation of patients with pelvic
floor dysfunctions and that they resemble other versions of the same questionnaire published in
other languages.
Keywords: pelvic floor dysfunctions; sexual dysfunction; urinary incontinence; prolapse; validation;
questionnaire; Spanish
1. Introduction
Pelvic floor dysfunction (PFD) is defined by Grimes and Stratton [1] and refers to a
wide range of symptoms, signs and anatomical changes related to the abnormal function
of the pelvic floor musculature and the structures with which it works synergistically. The
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pelvic floor is subjected to high pressures; its ability to resist them is due to the tonic-static
activity of the aponeurotic structures and muscles that form it, but if these structures are
weakened, hypotonic, or hypertonic, they are not able to readjust intra-abdominal pressure
(IAP) [2], poor proprioception or histological problems, and different pathologies can occur
that we can include in the concept of “pelvic floor dysfunction” [3–5]. PFD affects one
third of the adult female population [6] and includes a large number of clinical conditions,
such as urinary incontinence (UI), fecal incontinence (FI), pelvic organ prolapse (POP),
alterations in perception or filling of the lower urinary tract, defecatory disorders (DD),
sexual dysfunction and numerous chronic pain syndromes in the perineal area. This wide
variety of problems affects women 3 to 7 times more than men [7]. Pelvic floor problems
do not pose any risk to the lives of our patients, but we must be very aware of what they
cause. This pathology influences different aspects, such as social, physical, psychological,
occupational or sexual function, notably affecting the Quality of Life (QoL) of women who
suffer from them [8].
Since Engel [9] postulated the need for a holistic medical model, which he called
biopsychosocial, in response to the biomedical model, patient care has evolved towards
a patient-centered clinical practice [10]. This proposal was well received by the sectors
that wanted the incorporation of empathy and compassion in clinical practice. The biopsy-
chosocial model is committed to giving the patient a say in the care process, going from
being a mere object to being the subject of the clinical act [11]. Following this premise,
the questionnaires provide us with information about our patient’s self-perception and
facilitate the clinician’s access to this information. Having these data is essential to be able
to understand the evolution one is experiencing. The use of patient-reported outcome
measures (PROM) that ask patients to assess elements of their own health, QoL and func-
tionality is also interesting. These data can provide information about how an intervention
and treatment affect these aspects of a patient’s life [12].
For the evaluation of PFD, PFD assessment can be used, but it may vary depending
on the healthcare provider that evaluates it. Additionally, another point to keep in mind is
that there are patients who are not comfortable talking about this topic and are reluctant to
ask clinical staff about their PFD [13,14]. These are two of the reasons why it is important
to have questionnaires, for example PFDI-20 [8], PFIQ [8], IFSF [15], among others, that
can be completed autonomously and easily, since they are written so that they are easily
understood by patients [16].
Currently, the existence of tools such as validated questionnaires has become ex-
tremely important, since they allow us to objectively and subjectively evaluate the different
symptoms of pathologies that can be found in the day-to-day clinical practice based on
evidence [17]. The function of these questionnaires is mainly to facilitate objectively any re-
sponse or variation in the state of health according to the perception of the patient. Thanks
to them, clinicians can make a more complete diagnosis and carry out better management
of the symptoms in question. Many of these questionnaires are used today as a standard
protocol for measuring and managing a patient’s condition. All these measurement tools
that are used in both clinical practice and in research must first undergo a validation process
in which their psychometric characteristics are taken into account, as well as a validation
of the language and culture of the each clinical population group.
According to the latest update of the Cervantes Institute [18], more than 585 million
people speak Spanish worldwide, where almost 489 million are native Spanish speakers.
Spanish is also the second mother tongue of number of speakers and the third most-spoken
language globally after English and Mandarin Chinese [18]. Hence, the importance of
conducting a study that groups and classifies all the psychometric questionnaires that
evaluate the PFD existing up to now and that, in addition, are translated into Spanish
to facilitate and simplify the clinical practice of a very large community such as Spanish
speakers is clear.
The main objective of this study was to systematically review the existing scientific
literature on cross-cultural adapted and validated questionnaires into the Spanish language
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of Spain for the evaluation of the main dysfunctions of the pelvic floor. As a secondary
objective, the psychometric properties of the questionnaires that are located in the main
objective of this work will be reviewed.
2. Material and Method
2.1. Protocol
A systematic review of the literature was carried out following the general guidelines
and recommendations of the PRISMA statement [19] and was registered in the PROSPERO
database (CRD no.: 42021279944).
2.2. Sources and Search
For the development of this systematic review, a systematic search was carried out
in the PUBMED and WOS databases. The keywords used combined with the Boolean
operators “AND”/“OR” were: (“Fecal Incontinence” [Mesh]) OR “Urinary Incontinence”
[Mesh]) OR “Pelvic Organ Prolapse” [Mesh]) OR “Pelvic Floor Disorders” [Mesh]) OR
“Sexual Dysfunction, Physiological” [Mesh]) OR “Pelvic Girdle Pain” [Mesh]) OR “sexual
function” [Title/Abstract]) OR “Prolapse” [Title/Abstract]) AND “Surveys and Question-
naires” [Mesh] AND “Validation” [Title/Abstract]. In contrast, in WOS, a segregated
search was carried out with each of the terms of pelvic floor dysfunction together with
“Validation” and “Surveys and Questionnaires”. Articles published up to 19 November
2021 were considered.
2.3. Selection Criteria
The inclusion criteria used in this review were: cross-cultural adaptation and valida-
tion studies into Spanish (Spain) of questionnaires for the evaluation of the pelvic floor. All
articles that were published in a language other than Spanish or English were excluded, and
studies conducted only in women were considered. In addition, the methodological quality
of the studies was evaluated following the criteria of the Consensus-Based Standards for
the Selection of Health Measurement Instruments (COSMIN) tool [20]. The COSMIN scale
develops a set of relevant measurement properties to assess patient-reported outcome
measures (PROM) [21], which considers four domains: validity, reliability, responsiveness
and feasibility, with the related measurement properties and their characteristics. For
this study, it was decided to evaluate the domains of reliability (internal consistency and
reliability), validity and responsiveness.
2.4. Selection of Documents
The bibliographic citations identified were transferred to a tool to collect, examine
and evaluate the titles and summaries of the citations; this was the Rayyan platform
(rayyan.qcri.org) [22]. In the first place, the duplicate articles found were eliminated,
leaving a total of 13 documents.
Subsequently, two investigators (PGB-AGM) reviewed and screened independently
and blinded by title and abstract, and articles that did not meet the inclusion criteria were
eliminated. Those that, on the contrary, if they complied, were selected and located for
their full-text reading, articles that were in doubt or when the title and abstract did not
reveal enough information to determine their inclusion or exclusion were also retrieved.
Discrepancies were resolved by a third reviewer (GMT).
2.5. Results Synthesis and Data Extraction
All the articles that were finally selected were analyzed and processed in order to
identify validated questionnaires and gather information on the construction and validation
process of these tools. The data extracted from each instrument were: full name, acronym,
version, number of items, purpose of the questionnaire, scale, subscale, time to complete,
scoring scale. The psychometric aspects extracted were: test–retest reliability, internal
consistency, construct validity, content validity and standard error of measurement.
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3. Results
After identification of 687 documents (PubMed = 592) and WOS (n = 95) and elimina-
tion of 21 duplicates, 666 documents were selected. Of this number of articles, 634 were
finally excluded by reading the title and abstract, 18 for not being adaptations and valida-
tions of questionnaires or studying mixed or male population. Finally, we were left with a
total of 13 articles to carry out our systematic review, reflecting this entire selection process
in the flow diagram below (Figure 1).
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Figure 1. Instrument selection (flow chart).
After reading the titles and applying the selection criteria to the complete documents,
13 articles and a total of 15 question aires were selected [8,14,15,23–32].
These included four questionnaires that assess the QoL in people with PFD [15,26]:
Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7), Pelvic
Floor Distress Inventory Short Form (PFDI-20) and Pelvic Floor Impact Questionnaire Short
Form (PFIQ-7).
Four questionnaires assess the impact of PFD on a woman’s sexual life [15,24,25,31]:
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), Female
Int. J. Environ. Res. Public Health 2021, 18, 12858 5 of 17
Sexual Function Index (FSFI), Sexual Satisfaction Scale for Women (SSS-W-E), Pelvic Or-
gan Prolapse/Urinary Incontinence Sexual Questionnaire IUGA- Revised (PISQ-IR), and
Female Sexual Function Index in postmenopausal women (FSFI).
These questionnaires assess the symptoms of POP and UI as well as their classification
and severity and how they affect women [14,23,24,30,31]: Incontinence Questionnaire-Short
Form (ICIQ-SF), Bladder control Self-Assessment Questionnaire (B-SAQ), Prolapse and In-
continence Knowledge Questionnaire (PIKQ), Epidemiology of Prolapse and Incontinence
Questionnaire (EPIQ) and Prolapse Quality of Life Questionnaire (P-QoL). Also included is
a questionnaire that measures the expectations of self-efficacy and results in women with
pelvic floor disorders after performing exercises focused on this [27]: the Broome Pelvic
Muscle Self- Efficacy Scale.
Table 1 details the structural characteristics of the questionnaires. This table has been
structured in seven columns: acronym, number of items, population, purpose, dimensions,
subscale and punctuation. The number of items in the questionnaires varies from 6 from
the UDI-6 [26] to 53 items on the EPIQ [14]. All the included questionnaires were focused
only on women. The scoring scales vary greatly between the included studies, with
questionnaires that are scored from 0–100 (for example, PFDI-20 [8]), being more intuitive
and others from 0–10 (ex., EPIQ [14]).
Table 1. Structural characteristics of the questionnaires.
















Sum of the first















- 2: Discomfort andsymptoms
Likert scale: from



























0 = always to
4 = never),
reversing this
score for items 1,





















































From 0 to 4
Int. J. Environ. Res. Public Health 2021, 18, 12858 6 of 17
Table 1. Cont.
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Table 1. Cont.
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Table 2 shows the psychometric characteristics of the identified questionnaires. All
the questionnaires perform an analysis of internal consistency as well as test–retest relia-
bility, with the exception of the ICIQ-SF, B-SAQ and BPMSES in this last point. From the
14 questionnaires, 2.8 of them performed a factor analysis to identify different components
of the questionnaire. However, only five of them perform Kaiser–Meyer–Olkin analysis,
with values ranging between 0.721 and 0.921. It is important to highlight that the construct
validity is made by 14 questionnaires; however, the standardized error of the measurement
is the least studied psychometric variable in all the included questionnaires; specifically,
only four studies carry out the assessment of this important variable psychometric.
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AI: Anal Incontinence; DD: Defecatory Dysfunction; EPIQ: Epidemiology of Prolapse and Incontinence Questionnaire; FSD: Female
Sexual Dysfunction; FSFI: Female Sexual Function Index; ICC: Intraclass Correlation Coefficient; ICIQ-SF: International Consultation on
Incontinence Questionnaire Short-Form; KMO: Kaiser Meyer Olkin NSA: Non-Sexually Active women; OB: Overactive Bladder; PDE: Pain
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Table 3 shows the conclusions of all the studies analyzed. All of them conclude that
the translated and validated version in Spanish of each questionnaire meets the reliability
and validity requirements, and that they can be used in research and clinical practice.
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Table 3. General conclusions of the studies.
Study Conclusions
Espuña-Pons et al., 2004 [23] High sensitivity values and positive predictive values are indicators of the qualityof the questionnaire as an instrument diagnosis of UI.
Espuña-Pons et al., 2006 [24]
This questionnaire will be very useful both in clinical practice and in research,
allowing epidemiological studies of the prevalence of disease evaluated from the
point of view of the patient to be carried out.
Espuña-Pons et al., 2008 [25]
The Spanish version of the PISQ-12 complies with the psychometric properties of
feasibility, validity and reliability, to be used in our country, both in clinical
practice and in research.
Espuña-Pons et al., 2009 [14] The Spanish version of the EPIQ is feasible, valid and reliable to be used in clinicalpractice as a screening instrument for pelvic floor pathology.
Ruiz de Viñaspre et al., 2011 [26]
The results of the study show that both questionnaires constitute a reliable,
consistent and valid instrument to evaluate urogenital symptoms and their impact
on the QoL of pregnant women.
Sánchez-Sánchez et al., 2013 [8] ;
Sánchez-Sánchez, B., 2015 [33]
The Spanish versions of the PFDI-20 and PFIQ-7 are equivalent in content,
semantics, conceptually and idiomatically with the original versions, in addition to
being reliable, valid and feasible and responsive to evaluate the symptoms and
QoL in Spanish women with PFD.
Medrano-Sánchez et al., 2013 [27]
The Spanish version of the Broome questionnaire for self-efficacy is a useful
measurement tool for a relevant psychometric and clinical estimation of women in
performing pelvic floor exercises.
Mestre et al., 2017 [28] The Spanish version of the PISQ-IR meets the criteria of feasibility, validity andreliability for use in clinical practice.
Pérez-Herrezuelo et al., 2019 [29]
The Spanish version of the FSFI shows good internal consistency and test–retest
reliability, and also good construct, concurrent, and divergent validity for a
population of postmenopausal women, shows satisfactory general psychometric
properties and is able to discriminate between women with and without sexual
dysfunctions among a population of Spanish postmenopausal women.
Sánchez-Sánchez et al., 2020 [15] The Spanish version of the FSFI can be used as a reliable, valid, responsive andfeasible instrument to assess sexual function in women.
Sánchez-Sánchez et al., 2020 [30]
The Spanish version of the P-QoL has sufficient validity, reliability, responsiveness,
and feasibility for assessing the severity of symptoms and their impact on the QoL
of Spanish women with POP.
Sánchez-Sánchez et al., 2021 [31]
The Spanish PIKQ is a comprehensible, valid, reliable, feasible, and
responsive-to-change tool for assessing patient knowledge about UI and POP
conditions in the Spanish language, as well as the effect of educational treatment
strategies on them, both in research and clinical interventions.
Ruiz de Viñaspre-Hernández et al.,
2021 [32]
The Spanish version has good overall reliability and validity. The findings are
largely compatible with the initial hypothesis, which make the SSS-W-E a useful
tool for the evaluation of women’s sexual satisfaction in clinical practice and
research, in Spain.
4. Discussion
The objective of this systematic review was to carry out a synthesis analysis of vali-
dated psychometric questionnaires and with cross-cultural adaptation to Spanish for the
evaluation of the different or more prevalent PFD, to collect the structural and psychometric
characteristics of all the questionnaires and compare them to identify the most relevant
ones for use in clinical practice. Once the identification and analysis of the psychometric
characteristics of all the questionnaires had been carried out, a total of 15 questionnaires
were identified that were used in these studies, focused on the different pathologies of
pelvic floor. Within the questionnaires focused on PFD, QoL, sexual function, the impact of
POP and urine and stool losses, pain and disability were evaluated.
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Most of these questionnaires developed to assess QoL, pain, sexual function and
social impact are in English, and are used both in the clinical setting and in research on
Anglo-Saxon culture. There are more countries and cultures where clinical practice and
research environments use the same assessment and diagnostic tools, for example Spain.
The fact that most of the questionnaires are in English is the reason that they cannot
be used in all countries, since there is the problem of cultural and linguistic differences,
which can pose difficulties in terms of equivalence of the questionnaires translated from
the original versions. Therefore, the validation process in the desired language must be as
rigorous as possible and meet homogeneous standards. This process has to allow that the
diverse versions that are going to be realized and developed in different parts of the world
can be adapted culturally and linguistically, in addition to being comparable with each
other so that they can be used in higher evaluations, such as reviews and meta-analyses.
4.1. Selection and Use of Questionnaires in a Clinical and Research Setting
Four questionnaires have been identified that assess QoL [8,14,26,30], five of them mea-
sure the impact of PFD on sexual function [15,25,28,29,32], seven evaluate the symptoms
of POP and UI [8,14,25–27,30,31], and one was focused on pregnant women [26].
All questionnaires have a number of different psychometric characteristics, as well as a
different outcome variable. That is why, depending on the variable that is most interesting,
one questionnaire or another will be used, and it will be the clinician who makes this
decision depending on which one best suits the needs or objectives, time available, patient
profile, main variable of interest, etc.
To evaluate the QoL of people suffering from PFD, four questionnaires were
found [8,14,26,30], as already mentioned above. These questionnaires, despite evalu-
ating the QoL, do not contemplate the area of sexual function and do not contain questions
that deal with it; therefore, it is necessary to have other tools that do take it into account.
For example, the EPIQ [14] contains 53 items and each item has a range from 0 to 10. The
P-QoL [30] contains 20 items and the scale ranges from 0 to 100, the IIQ-7 [26] contains
7 items and the scale ranges from 0 to 3, and finally, the PFDI-20 [8] contains 20 items
distributed in 3 blocks with a maximum score of 300.
Sexual function can be assessed with the five questionnaires that have been found in
the studies (PISQ-12 [25], PISQ-IR [28], FSFI-postmenopausal [29], FSFI [15], SSS-W-E [32]).
The main differences between the PISQ-IR and the PISQ-12 are found in the PISQ-IR
difference between sexually active and non-active women [28], but both are focused on
sexual function within pelvic floor dysfunctions. The PISQ-IR [28] is a review carried out
by the IUGA of the two previous questionnaires and consists of 20 items. The most widely
used questionnaire to assess sexual function in women is the FSFI-postmenopausal [29]
and FSFI [15], which consists of 19 items that measure sexual dysfunction in six domains
according to the woman’s perception (desire, arousal, lubrication, orgasm, satisfaction and
pain) and is considered the “gold standard” to evaluate sexual function in women. The
main difference between these two questionnaires is that one of them has been validated in
postmenopausal women [29].
If the purpose is to evaluate POP, we find the P-QoL [30] with 20 items and the
EPIQ [14] with 53, and the PIKQ [31] with 24 items. The P-QoL and EPIQ arises from the
need to have a tool that evaluates the QoL specifically in women with prolapse, since the
PIKQ focuses on the woman’s own knowledge of her prolapse. According to Sánchez-
Sánchez et al. [30], the P-QoL assesses the severity of symptoms and the impact on QoL, in
addition to serving as a guide to choose the most appropriate treatment in each case, being
surgical or conservative and also offering the option of evaluating its effectiveness.
The pathology for which most questionnaires were found was UI, with a total of
eight: ICIQ-SF [23], B-SAQ [24], PISQ-12 [25], EPIQ [14], UDI-6 [26], IIQ-7 [26], Broome [27]
and PIKQ [31]. In addition to evaluating the UI, it also has sections where it evaluates
general data and gynecological history, general health data, overactive bladder syndrome,
questions about QoL affection, genital prolapse, anal incontinence, pain and emptying
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difficulty, defecatory dysfunction, sexual life and sociodemographic data. Additionally, on
the other hand, the PIKQ focuses on the woman’s own knowledge about UI.
Lastly, the Broome Pelvic Muscle Self-Efficacy Scale [27], as its name indicates, mea-
sures self-efficacy in performing pelvic floor exercises and takes into account the dimensions
of self-efficacy and outcome expectations.
4.2. Psychometric Characteristics of the Questionnaires That Assess QoL
The four questionnaires [8, 14, 26, 30] identified for the evaluation of the QoL in women
with pelvic floor problems had reliability values that ranged from 0.64 [8] to 0.95 [26]. This
psychometric variable was in line with other versions of the same questionnaire. For
example, in the study by Sánchez-Sánchez et al. [4], the PFIQ-7 and the PFDI-20 have a
test–retest reliability very similar to that of the versions in other languages, such as Chinese,
Swedish or Turkish [34–36], and we could also confirm a very good reliability, from 0.89 to
0.99, in African languages [37].
When analyzing the construct validity, Sánchez-Sánchez et al. [8] obtained a good
relationship between the SF-12 Health Survey and the Spanish versions of the PFDI-20 and
PFIQ-7. When comparing the PFDI-20 and PFIQ-7 with the EPIQ [14] and ICIQ-SF [23], the
scores for the dimensions that measured the same symptoms showed a high correlation.
Regarding internal consistency, Cronbach’s alpha ranges between 0.837 for the PFDI-20
and 0.96 for the EPIQ. Regarding construct validity, only the EPIQ did not include external
validity, while the others were compared with more than one gold standard. In relation
to other adapted and validated versions of the PFDI-20 and PFIQ-7, it can be observed
that similar results are obtained in relation to internal consistency, such as, for example,
in African languages [37], for the PFDI-20 (0.71–0.89) and the PFIQ-7 (0.81–0.89). On the
other hand, the original versions of the PFDI and PFIQ [38] showed very good internal
consistency with alpha values of 0.88 and 0.97, respectively. This agreement was confirmed
with the development of the short form versions of these questionnaires.
4.3. Psychometric Characteristics of the Questionnaires That Assess Sexual Function
There are five validated questionnaires in Spanish for the evaluation of sexual func-
tion [15,25,28,29,32], as already mentioned. In three of the studies the test–retest reliability
was calculated, for example FSFI [15] with an ICC value of 0.96, and PISQ-12 [25] with
an ICC value between 0.22 and 0.76. On the other hand, the ICC values of the Spanish
FSFI-postmenopausal [29] were substantial-to-excellent for the FSFI total score, with ICC
values ranging between 0.884 and 0.972, which are comparable with those described by
Takahashi et al. [39] in the analysis of the Japanese version of FSFI. In the case of the
PISQ-12 [25], the best ICC value between the Spanish and English versions had a value of
0.76, showing that there was equivalence between both versions.
The internal consistency was calculated for the questionnaires related to sexual func-
tion, where Cronbach’s alpha oscillates between 0.79 of the PISQ-IR [28] and 0.964 of the
FSFI-postmenopausal [29]. However, in the German version of the PISQ-IR, Cronbach’s
alpha coefficients ranged from 0.64 to 0.94 [40]. On the other hand, in the original FSFI
validation, Rosen et al. [40] described a high degree of internal consistency, with Cronbach’s
alpha values of 0.89 and higher, and 0.97 for the total FSFI score. In addition, a validation
of the Persian version [41] reported a Cronbach’s alpha greater than 0.80 for the entire
scale and its dimensions, and at the same time in the Italian version [42] Cronbach’s alpha
coefficients for total and domain score were sufficiently high, ranging from 0.92 to 0.97 for
the total sample.
The construct validity was calculated with a gold standard in the PISQ-12, the PISQ-
IR and FSFI-postmenopausal questionnaires. However, regarding the validity of the
convergent construct, it was only calculated in the FSFI, where the highest correlations
found were between arousal and desire, orgasm and satisfaction, and between orgasm and
satisfaction, coinciding with the result of the original study. In the case of the PISQ-IR [28],
factor analysis showed that the Spanish version had a similar structure to the English one.
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4.4. Psychometric Characteristics of the Questionnaires That Evaluate POP
The test–retest reliability of the three questionnaires that evaluate the POP is high,
being between 0.49 and 0.91 in the case of the EPIQ [14], 0.791 in the P-QoL [30] and 0.977
in the PIKQ [31]. However, in the case of the P-QoL questionnaire in relation to other
versions [43–52], the majority of studies scored poorly for test–retest reliability largely due
to the small sample sizes, poor description of test conditions, and poor stability of the
retest sample.
Internal consistency was also calculated in the three instruments where Cronbach’s
alpha coefficient had a value of 0.94 in the EPIQ [14] compared to 0.91 obtained in the
original version [53]. On the other hand, in the PIKQ [31], Cronbach’s alpha coefficients
were 0.745 and 0.758 for the UI and POP dimensions, respectively, and to the same degree
as the original version [54] (0.825 and 0.895, respectively) and the Turkish version [55]
(0.678 and 0.756, respectively). This shows that when all the elements measure the same
construct, the intercorrelations between items increase. This coefficient was also calculated
for seven dimensions identified in the EPIQ (QoL, overactive bladder, fecal incontinence,
pain and difficulty emptying, defecatory dysfunction, stress urinary incontinence and
POP), and in some cases they were higher than those obtained in the original version. In
the P-QoL [30], this coefficient obtained high values of internal consistency and ranged
between 0.550-0.877, with the exception of the dimensions “sleep/energy” and “severity
measures”, which were acceptable (0.621 and 0.550, respectively). In addition, in other
versions of the P-QoL analyzed, the scores were excellent [43,48–50,56] and good [47,51,57]
scores were found in some other versions, but in most studies, the questionnaire displayed
adequate evidence with Cronbach’s alpha values ≥0.7.
The construct validity was analyzed in the study carried out by Sánchez-Sánchez et al. [30]
and they verified that there were high values and, therefore, a good relationship for
the P-QoL dimension and the PFDI-20 and PFIQ-7 questionnaires. For the evaluation
of this psychometric characteristic, Espuña-Pons et al. [14] carried out a factor analysis
of the seven previous dimensions, which were also identified in the original version
of the questionnaire: QoL, fecal incontinence, pain and difficulty emptying, defecatory
dysfunction, stress urinary incontinence and POP.
4.5. Psychometric Characteristics of the Questionnaires That Evaluate UI
Of the eight questionnaires identified for the evaluation of UI (ICIQ-SF, B-SAQ, PISQ-
12, EPIQ, UDI-6, IIQ-7, Broome and PIKQ [14,23–27,31]), only the value taken by the ICC is
available in five questionnaires [14,25,26,32], oscillating between 0.22 [25] and 0.99 [32].
Internal consistency was also calculated in all the instruments where Cronbach’s
alpha coefficient took a value between 0.667 and 0.94. In the specific case of the EPIQ
questionnaire, this coefficient took the value 0.94 for the total of the items compared to
0.91 obtained in the original version [53]. At the same time, for the ICIQ-SF questionnaire,
Cronbach’s alpha was calculated for the three items of the questionnaire (“frequency”,
“quantity” and “affectation”), which was 0.89, resulting in being high and being practically
similar to the Portuguese version [58], with a Cronbach alpha of 0.88. It is also worth
noting, in the Broome questionnaire, that the Cronbach alpha coefficient was extremely
high (0.91) and very close to that of the original version (0.997) [59].
4.6. Responsiveness
Responsiveness or sensitivity to change was measured in only five question-
naires [15,30,31,33]. Responsiveness is the ability to detect changes that occur as a re-
sult of therapy or disease progression and has been suggested as one criterion to choose
among the scales used to evaluate the efficacy of a therapeutic intervention. In the case
of PFDI-20, PFIQ-7 and P-QoL [30,33], were assessed with pre- and post-physiotherapy,
implying that PFDI-20, PFIQ-7 and P-QoL [30,33] responsiveness can be detected to assess
changing quality of life with a small change in score after physiotherapy. On the other
hand, the UI and POP sections of the Spanish version of the PIKQ [31] show an excellent
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response capacity in women after a physiotherapy treatment that included pelvic health
education interventions.
4.7. Limitations
It should be noted that some limitations were observed in the tools analyzed. Many
of them do not have psychometric variables as important as sensitivity or error measures.
Therefore, in the future it is convenient to design studies that analyze these psychometric
variables, which are of great importance in research, especially in the clinical setting.
On the other hand, it is very important to take into account that native Spanish
is a language spoken by more than 489 million people in the world, being the second
most widely spoken language after Mandarin Chinese [18]. This group of people are in
different countries. For this reason, it is essential to consider the cultural characteristics
of each population group that could condition the interpretation of the questions and
the answers obtained. In this sense, if the sociodemographic and cultural differences
are substantial, it would be necessary to develop a specific version, fully adapted to the
population group of interest. This last point was not a limitation in the present study,
since these sociodemographic and cultural differences were taken into account, but it is
considered important to highlight it, since many of the studies used consider it that way.
5. Conclusions
The main conclusion that can be drawn from this study is that the Spanish versions
of the questionnaires show good basic structural and psychometric characteristics for the
evaluation of patients with PFD and pathologies. Spanish clinicians have different instru-
ments with psychometric characteristics that, as a general rule, resemble other versions of
the same questionnaire published in other languages.
Therefore, these characteristics would allow the results obtained to be compared with
samples from other countries. Despite these good characteristics, there are psychometric
variables that none of the questionnaires selected in this study include. Therefore, it is
necessary to design studies that include psychometric variables so that the validation
process is homogeneous and identical for the scientific community. With regard to the
responsiveness, only five questionnaires included this relevant analysis. The relevance of
responsiveness lies in assessing the changes related to therapeutic interventions and must
be considered in these kinds of questionnaires in future studies.
Thanks to this study it can be concluded that the psychometric questionnaires for the
evaluation of pelvic floor available so far, and that have been included in this study, that
are translated and validated into Spanish are those that assess QoL, the impact of PFD on
sexual function, the symptoms and impact of POP and UI, and, finally, that also assess
self-efficacy and outcome expectations in women with PFD after performing exercises
focused on this.
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